Competing Risks and Their Impact on Treatment Efficacy Assessment in Fractionated Stereotactic Radiotherapy for Brain Metastases: A Retrospective Study
This study highlights the impact of statistical method selection on clinical data interpretation and underscores the bias inherent in studies that fail to account for competing risks. Recognizing these differences is crucial for accurately assessing treatment outcomes.
Authors
- Isabella Gruber (ORCID: https://orcid.org/0000-0002-7435-9337)
- Oliver Koelbl
Institutions
- University Hospital Regensburg (DE)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/hsr2.70447
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00